Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

. 2016 Jan ; 131 (1) : 87-102. [epub] 20151210

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S., přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid26659578

Grantová podpora
P50 AG05136 NIA NIH HHS - United States
P30 AG010133 NIA NIH HHS - United States
P30 AG013846 NIA NIH HHS - United States
P01 AG019724-03 NIA NIH HHS - United States
AG010124 NIA NIH HHS - United States
G0900580 Medical Research Council - United Kingdom
R01 NS095252 NINDS NIH HHS - United States
Arthritis Research UK - United Kingdom
P50 AG005138 NIA NIH HHS - United States
R28 AA012725 NIAAA NIH HHS - United States
G0901945 Medical Research Council - United Kingdom
P50AG05146 NIA NIH HHS - United States
P30 AG028383 NIA NIH HHS - United States
P30AG008051-26 NIA NIH HHS - United States
P30 AG013854 NIA NIH HHS - United States
G0900582 Medical Research Council - United Kingdom
MR/L016451/1 Medical Research Council - United Kingdom
P50 AG05681 NIA NIH HHS - United States
P30 AG010124 NIA NIH HHS - United States
P50 AG023501 NIA NIH HHS - United States
G1100540 Medical Research Council - United Kingdom
P30 AG10133 NIA NIH HHS - United States
P50 AG016574 NIA NIH HHS - United States
P50 AG005146 NIA NIH HHS - United States
P01 AG017586 NIA NIH HHS - United States
AG017586 NIA NIH HHS - United States
R01 AG040311 NIA NIH HHS - United States
AG028383 NIA NIH HHS - United States
U01 NS086659 NINDS NIH HHS - United States
MR/L016400/1 Medical Research Council - United Kingdom
P01 AG003991 NIA NIH HHS - United States
P30 AG008051 NIA NIH HHS - United States
P50 AG005681 NIA NIH HHS - United States
P30AG12300 NIA NIH HHS - United States
P01 AG03991 NIA NIH HHS - United States
R01 NS094003 NINDS NIH HHS - United States
P50 AG005136 NIA NIH HHS - United States
P30 AG012300 NIA NIH HHS - United States
G0900652 Medical Research Council - United Kingdom
P01 AG019724 NIA NIH HHS - United States
G0502157 Medical Research Council - United Kingdom
G0400074 Medical Research Council - United Kingdom
P50 NS072187 NINDS NIH HHS - United States
P50 AG005133 NIA NIH HHS - United States
P50 NS062684 NINDS NIH HHS - United States
AG13854 NIA NIH HHS - United States
1U01NS086659-01 NINDS NIH HHS - United States
P30AG13846 NIA NIH HHS - United States
G0600953 Medical Research Council - United Kingdom
MC-PC-13044 Medical Research Council - United Kingdom

Odkazy

PubMed 26659578
PubMed Central PMC4879001
DOI 10.1007/s00401-015-1509-x
PII: 10.1007/s00401-015-1509-x
Knihovny.cz E-zdroje

Pathological accumulation of abnormally phosphorylated tau protein in astrocytes is a frequent, but poorly characterized feature of the aging brain. Its etiology is uncertain, but its presence is sufficiently ubiquitous to merit further characterization and classification, which may stimulate clinicopathological studies and research into its pathobiology. This paper aims to harmonize evaluation and nomenclature of aging-related tau astrogliopathy (ARTAG), a term that refers to a morphological spectrum of astroglial pathology detected by tau immunohistochemistry, especially with phosphorylation-dependent and 4R isoform-specific antibodies. ARTAG occurs mainly, but not exclusively, in individuals over 60 years of age. Tau-immunoreactive astrocytes in ARTAG include thorn-shaped astrocytes at the glia limitans and in white matter, as well as solitary or clustered astrocytes with perinuclear cytoplasmic tau immunoreactivity that extends into the astroglial processes as fine fibrillar or granular immunopositivity, typically in gray matter. Various forms of ARTAG may coexist in the same brain and might reflect different pathogenic processes. Based on morphology and anatomical distribution, ARTAG can be distinguished from primary tauopathies, but may be concurrent with primary tauopathies or other disorders. We recommend four steps for evaluation of ARTAG: (1) identification of five types based on the location of either morphologies of tau astrogliopathy: subpial, subependymal, perivascular, white matter, gray matter; (2) documentation of the regional involvement: medial temporal lobe, lobar (frontal, parietal, occipital, lateral temporal), subcortical, brainstem; (3) documentation of the severity of tau astrogliopathy; and (4) description of subregional involvement. Some types of ARTAG may underlie neurological symptoms; however, the clinical significance of ARTAG is currently uncertain and awaits further studies. The goal of this proposal is to raise awareness of astroglial tau pathology in the aged brain, facilitating communication among neuropathologists and researchers, and informing interpretation of clinical biomarkers and imaging studies that focus on tau-related indicators.

Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK

Civin Laboratory for Neuropathology Banner Sun Health Research Institute Sun City AZ 85351 USA

Clinical Neuropathology King's College Hospital London Neurodegenerative Brain Bank London UK

Department of Anatomical Pathology Alfred Hospital Prahran VIC 3004 Australia

Department of Immunology Genetics and Pathology Uppsala University Uppsala Sweden

Department of Medicine Imperial College London London UK

Department of Mental Health and Psychiatry University Hospitals and University of Geneva School of Medicine Geneva Switzerland

Department of Neurological Sciences Rush University Medical Center Chicago IL USA

Department of Neurology and Neurobiology of Aging Kanazawa University Graduate School of Medical Sciences Kanazawa Japan

Department of Neurology and Pathology Boston University School of Medicine and VA Healthcare System Boston MA 02118 USA

Department of Neurology and Sanders Brown Center on Aging University of Kentucky Lexington KY 40536 USA

Department of Neurology Brain Research Institute University of California Los Angeles Medical Center and David Geffen School of Medicine Los Angeles CA USA

Department of Neurology Center for Cognitive Neurology New York University School of Medicine ERSP 450 East 29th Street New York NY 10016 USA

Department of Neurology Medical University of Vienna Vienna Austria

Department of Neurology Memory and Aging Center University of California San Francisco USA

Department of Neurology Saitama Medical University International Medical Center Saitama Japan

Department of Neuropathology Faculty of Medicine Institute of Pathology University of Debrecen Nagyerdei krt 98 4032 Debrecen Hungary

Department of Neuropathology John Radcliffe Hospital Oxford UK

Department of Neuropathology Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology Tokyo Japan

Department of Neuropathology Walton Centre Liverpool UK

Department of Neuroscience KU Leuven 3000 Louvain Belgium

Department of Neuroscience Mayo Clinic 4500 San Pablo Road Jacksonville FL 32224 USA

Department of Pathology and Immunology Washington University School of Medicine St Louis MO USA

Department of Pathology and Laboratory Medicine Centre for Cancer Therapeutics Ottawa Hospital Research Institute University of Ottawa Ottawa Canada

Department of Pathology and Laboratory Medicine Indiana University School of Medicine Indianapolis IN USA

Department of Pathology and Laboratory Medicine of the Perelman School of Medicine Center for Neurodegenerative Disease Research Institute On Aging University of Pennsylvania Philadelphia USA

Department of Pathology and Laboratory Medicine University of British Columbia Vancouver Canada

Department of Pathology and Molecular Medicine Thomayer Hospital Prague 4 Czech Republic

Department of Pathology and Neuropathology Laboratory of Neuropathology Neuromed Campus Kepler University Hospital Medical School Johannes Kepler University Linz Austria

Department of Pathology and Sanders Brown Center on Aging University of Kentucky Lexington KY 40536 USA

Department of Pathology Brain Research Institute Niigata University Niigata 951 8585 Japan

Department of Pathology Brigham and Women's Hospital Harvard Medical School Boston MA USA

Department of Pathology Center for Cognitive Neurology New York University School of Medicine ERSP 450 East 29th Street New York NY 10016 USA

Department of Pathology Friedman Brain Institute and the Ronald M Loeb Center for Alzheimer's Disease Icahn School of Medicine at Mount Sinai New York USA

Department of Pathology LIM 22 University of Sao Paulo Medical School Sao Paulo Brazil

Department of Pathology Rush University Medical Center Chicago IL USA

Department of Pathology University of Pittsburgh Pittsburgh PA USA

Department of Pathology University of Texas Southwestern Medical Center Dallas TX USA

Department of Pathology University of Washington Seattle WA USA

Department of Psychiatry and Psychotherapy Centre for Neuropathology and Prion Research Ludwig Maximilians University Munich Munich Germany

Department of Psychiatry Center for Cognitive Neurology New York University School of Medicine ERSP 450 East 29th Street New York NY 10016 USA

Discipline of Pathology Sydney Medical School The University of Sydney Sydney NSW 2006 Australia

Division of Neuropathology Department of Pathology Johns Hopkins University School of Medicine Baltimore MD USA

Division of Pathology St Michael's Hospital 30 Bond St Toronto ON Canada

Fishberg Department of Neuroscience Friedman Brain Institute and Ronald M Loeb Center for Alzheimer's Disease Icahn School of Medicine at Mount Sinai New York NY 10029 USA

GMH Neuroscience Research Australia and the University of New South Wales Sydney NSW Australia

Institute for Neurodegenerative Diseases University of California San Francisco San Francisco CA USA

Institute of Brain Behaviour and Mental Health Manchester University Faculty of Medical and Health Sciences Manchester UK

Institute of Clinical Neurobiology Alberichgasse 5 13 1150 Vienna Austria

Institute of Clinical Neurosciences University of Bristol Learning and Research Level 2 Southmead Hospital Bristol UK

Institute of Neuroanatomy Centre for Biomedicine and Medical Technology Mannheim Medical Faculty Mannheim Heidelberg University Heidelberg Germany

Institute of Neurology Medical University of Vienna AKH 4J Währinger Gürtel 18 20 1097 Vienna Austria

Institute of Neuropathology Bellvitge University Hospital University of Barcelona Hospitalet de Llobregat Barcelona Spain

Institute of Neuropathology University Hospital Zürich Zurich Switzerland

Institute of Neuroscience Newcastle University Newcastle upon Tyne UK

Institute of Pathology University Hospital Basel Basel Switzerland

IRCCS Foundation Carlo Besta Neurological Institute Milan Italy

Laboratory of Neuropathology Institute of Pathology University of Ulm 89081 Ulm Germany

Netherlands Brainbank and Department of Pathology VU University Medical Center Amsterdam The Netherlands

Neurological Tissue Bank of the Biobank Hospital Clinic IDIBAPS Institut d'Investigacions Biomediques August Pi i Sunyer Barcelona Spain

Neuropathology Department Hopital de La Salpetrière AP HP UPMC Sorbonne University Paris France

Northwestern ADC Neuropathology Core Northwestern University Feinberg School of Medicine Chicago IL USA

Physiopathology in Aging Lab Brazilian Aging Brain Study Group LIM22 University of Sao Paulo Medical School Sao Paulo Brazil

Section of Neuropathology Department of Pathology and Laboratory Medicine Brain Research Institute University of California Los Angeles Medical Center and David Geffen School of Medicine Los Angeles CA USA

Sheffield Institute for Translational Neuroscience University of Sheffield Sheffield UK

Zobrazit více v PubMed

Ahmed Z, Bigio EH, Budka H, Dickson DW, Ferrer I, Ghetti B, Giaccone G, Hatanpaa KJ, Holton JL, Josephs KA, et al. Globular glial tauopathies (GGT): consensus recommendations. Acta Neuropathol. 2013;126:537–544. PubMed PMC

Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, et al. Staging of neurofibrillary pathology in Alzheimer’s disease: a study of the BrainNet Europe Consortium. Brain Pathol. 2008;18:484–496. PubMed PMC

Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, et al. Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol. 2009;117:635–652. PubMed

Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I, Boluda S, Bugiani O, Duyckaerts C, Gelpi E, et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol. 2009;117:309–320. PubMed PMC

Arima K, Izumiyama Y, Nakamura M, Nakayama H, Kimura M, Ando S, Ikeda K, Takahashi K. Argyrophilic tau-positive twisted and non-twisted tubules in astrocytic processes in brains of Alzheimer-type dementia: an electron microscopical study. Acta Neuropathol. 1998;95:28–39. PubMed

Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res. 1989;477:90–99. PubMed

Beach TG, Sue L, Scott S, Layne K, Newell A, Walker D, Baker M, Sahara N, Yen SH, Hutton M, et al. Hippocampal sclerosis dementia with tauopathy. Brain Pathol. 2003;13:263–278. PubMed PMC

Beach TG, Walker R, McGeer EG. Patterns of gliosis in Alzheimer’s disease and aging cerebrum. Glia. 1989;2:420–436. PubMed

Bigio EH, Mishra M, Hatanpaa KJ, White CL, 3rd, Johnson N, Rademaker A, Weitner BB, Deng HX, Dubner SD, Weintraub S, et al. TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Acta Neuropathol. 2010;120:43–54. PubMed PMC

Boluda S, Toledo JB, Irwin DJ, Raible KM, Byrne MD, Lee EB, Lee VM, Trojanowski JQ. A comparison of Abeta amyloid pathology staging systems and correlation with clinical diagnosis. Acta Neuropathol. 2014;128:543–550. PubMed PMC

Botez G, Probst A, Ipsen S, Tolnay M. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease. Acta Neuropathol. 1999;98:251–256. PubMed

Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL, 3rd, Schneider JA, Grinberg LT, Halliday G, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114:5–22. PubMed PMC

Chin SS, Goldman JE. Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol. 1996;55:499–508. PubMed

Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128:755–766. PubMed PMC

Dickson DW, Kouri N, Murray ME, Josephs KA. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau) J Mol Neurosci. 2011;45:384–389. PubMed PMC

Dugger B, Uchikado H, Ahmed Z, Dickson DW. Sex differences in perivascular tauopathy in the mediobasal tuberal hypothalamus in neurodegenerative diseases in humans. Alzheimers Dementia. 2008;4(Suppl):T715.

Dugger BN, Hentz JG, Adler CH, Sabbagh MN, Shill HA, Jacobson S, Caviness JN, Belden C, Driver-Dunckley E, Davis KJ, et al. Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. J Neuropathol Exp Neurol. 2014;73:244–252. PubMed PMC

Evidente VG, Adler CH, Sabbagh MN, Connor DJ, Hentz JG, Caviness JN, Sue LI, Beach TG. Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP? Parkinsonism Relat Disord. 2011;17:365–371. PubMed PMC

Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol. 1995;146:1388–1396. PubMed PMC

Ferrer I, Legati A, Garcia-Monco JC, Gomez-Beldarrain M, Carmona M, Blanco R, Seeley WW, Coppola G. Familial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathy. J Neuropathol Exp Neurol. 2015;74:370–379. PubMed PMC

Ferrer I, Lopez-Gonzalez I, Carmona M, Arregui L, Dalfo E, Torrejon-Escribano B, Diehl R, Kovacs GG. Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol. 2014;73:81–97. PubMed

Ferrer I, Santpere G, van Leeuwen FW. Argyrophilic grain disease. Brain. 2008;131:1416–1432. PubMed

Ghetti B, Oblak AL, Boeve BF, Johnson KA, Dickerson BC, Goedert M. Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol. 2015;41:24–46. PubMed PMC

Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron. 1989;3:519–526. PubMed

Hishikawa N, Hashizume Y, Yoshida M, Niwa J, Tanaka F, Sobue G. Tuft-shaped astrocytes in Lewy body disease. Acta Neuropathol. 2005;109:373–380. PubMed

Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702–705. PubMed

Ikeda K. Glial fibrillary tangles and argyrophilic threads: classification and disease specificity. Neuropathology. 1996;16:71–77.

Ikeda K, Akiyama H, Arai T, Nishimura T. Glial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles. Neurobiol Aging. 1998;19:S85–S91. PubMed

Ikeda K, Akiyama H, Kondo H, Haga C, Tanno E, Tokuda T, Ikeda S. Thorn-shaped astrocytes: possibly secondarily induced tau-positive glial fibrillary tangles. Acta Neuropathol. 1995;90:620–625. PubMed

Irwin DJ, Cairns NJ, Grossman M, McMillan CT, Lee EB, Van Deerlin VM, Lee VM, Trojanowski JQ. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol. 2015;129:469–491. PubMed PMC

Jellinger KA, Attems J. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol. 2007;113:107–117. PubMed

Kovacs GG. Invited review: neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol. 2015;41:3–23. PubMed

Kovacs GG, Horvath MC, Majtenyi K, Lutz MI, Hurd YL, Keller E. Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions. Neurobiol Aging. 2015;36:3100–3107. PubMed PMC

Kovacs GG, Milenkovic I, Wohrer A, Hoftberger R, Gelpi E, Haberler C, Honigschnabl S, Reiner-Concin A, Heinzl H, Jungwirth S, et al. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol. 2013;126:365–384. PubMed

Kovacs GG, Molnar K, Laszlo L, Strobel T, Botond G, Honigschnabl S, Reiner-Concin A, Palkovits M, Fischer P, Budka H. A peculiar constellation of tau pathology defines a subset of dementia in the elderly. Acta Neuropathol. 2011;122:205–222. PubMed

Lace G, Ince PG, Brayne C, Savva GM, Matthews FE, de Silva R, Simpson JE, Wharton SB. Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort. Dement Geriatr Cogn Disord. 2012;34:15–24. PubMed

Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci. 2001;24:1121–1159. PubMed

Lopez-Gonzalez I, Carmona M, Blanco R, Luna-Munoz J, Martinez-Mandonado A, Mena R, Ferrer I. Characterization of thorn-shaped astrocytes in white matter of temporal lobe in Alzheimer’s disease brains. Brain Pathol. 2013;23:144–153. PubMed PMC

Love S, Miners JS. White matter hypoperfusion and damage in dementia: post-mortem assessment. Brain Pathol. 2015;25:99–107. PubMed PMC

McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, Santini VE, Lee HS, Kubilus CA, Stern RA. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol. 2009;68:709–735. PubMed PMC

McKee AC, Stein TD, Kiernan PT, Alvarez VE. The neuropathology of chronic traumatic encephalopathy. Brain Pathol. 2015;25:350–364. PubMed PMC

McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, Lee HS, Wojtowicz SM, Hall G, Baugh CM, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136:43–64. PubMed PMC

Mesulam M, Wicklund A, Johnson N, Rogalski E, Leger GC, Rademaker A, Weintraub S, Bigio EH. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol. 2008;63:709–719. PubMed PMC

Milenkovic I, Petrov T, Kovacs GG. Patterns of hippocampal tau pathology differentiate neurodegenerative dementias. Dement Geriatr Cogn Disord. 2014;38:375–388. PubMed

Montine TJ, Monsell SE, Beach TG, Bigio EH, Yunqi B, Cairns NJ, Frosch M, Henriksen J, Julia K, Kukull WA, et al. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer’s disease. Alzheimers Dementia. 2015 doi: 10.1016/j.jalz.2015.07.492. PubMed DOI PMC

Munoz DG, Woulfe J, Kertesz A. Argyrophilic thorny astrocyte clusters in association with Alzheimer’s disease pathology in possible primary progressive aphasia. Acta Neuropathol. 2007;114:347–357. PubMed

Murray ME, Kouri N, Lin WL, Jack CR, Jr, Dickson DW, Vemuri P. Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias. Alz Res Ther. 2014;6:1. PubMed PMC

Nakano I, Iwatsubo T, Otsuka N, Kamei M, Matsumura K, Mannen T. Paired helical filaments in astrocytes: electron microscopy and immunohistochemistry in a case of atypical Alzheimer’s disease. Acta Neuropathol. 1992;83:228–232. PubMed

Nishimura M, Namba Y, Ikeda K, Oda M. Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy. Neurosci Lett. 1992;143:35–38. PubMed

Oberheim NA, Goldman SA, Nedergaard M. Heterogeneity of astrocytic form and function. Methods Mol Biol. 2012;814:23–45. PubMed PMC

Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol. 1998;43:815–825. PubMed

Sakai K, Piao YS, Kikugawa K, Ohara S, Hasegawa M, Takano H, Fukase M, Nishizawa M, Kakita A, Takahashi H. Corticobasal degeneration with focal, massive tau accumulation in the subcortical white matter astrocytes. Acta Neuropathol. 2006;112:341–348. PubMed

Santpere G, Ferrer I. Delineation of early changes in cases with progressive supranuclear palsy-like pathology. Astrocytes in striatum are primary targets of tau phosphorylation and GFAP oxidation. Brain Pathol. 2009;19:177–187. PubMed PMC

Schultz C, Braak H, Braak E. A sex difference in neurodegeneration of the human hypothalamus. Neurosci Lett. 1996;212:103–106. PubMed

Schultz C, Dehghani F, Hubbard GB, Thal DR, Struckhoff G, Braak E, Braak H. Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons. J Neuropathol Exp Neurol. 2000;59:39–52. PubMed

Schultz C, Ghebremedhin E, Braak E, Braak H. Sex-dependent cytoskeletal changes of the human hypothalamus develop independently of Alzheimer’s disease. Exp Neurol. 1999;160:186–193. PubMed

Schultz C, Ghebremedhin E, Del Tredici K, Rub U, Braak H. High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe. Neurobiol Aging. 2004;25:397–405. PubMed

Shimizu H, Kakita A, Takahashi H. Spinal cord tau pathology in cervical spondylotic myelopathy. Acta Neuropathol. 2008;115:185–192. PubMed

Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, Savva G, Brayne C, Wharton SB, Function MRCC, et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging. 2010;31:578–590. PubMed

Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119:7–35. PubMed PMC

Sosunov AA, Wu X, Tsankova NM, Guilfoyle E, McKhann GM, 2nd, Goldman JE. Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain. J Neurosci. 2014;34:2285–2298. PubMed PMC

Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MR, Ghetti B. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci USA. 1997;94:4113–4118. PubMed PMC

Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA. 1998;95:7737–7741. PubMed PMC

Thomas T, Miners S, Love S. Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer’s disease and vascular dementia. Brain. 2015;138:1059–1069. PubMed

Togo T, Dickson DW. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol. 2002;104:398–402. PubMed

Uchikado H, Fujino Y, Lin W, Dickson D. Advances in Alzheimer’s and Parkinson’s disease: insights, progress, and perspectives. New York: 2008. Frequency and relation of argyrophilic grain disease and thorn-shaped astrocytes in Alzheimer’s disease; pp. 375–379.

Wakabayashi K, Shibasaki Y, Hasegawa M, Horikawa Y, Soma Y, Hayashi S, Morita T, Iwatsubo T, Takahashi H. Primary progressive aphasia with focal glial tauopathy. Neuropathol Appl Neurobiol. 2000;26:477–481. PubMed

Yamazaki M, Nakano I, Imazu O, Terashi A. Paired helical filaments and straight tubules in astrocytes: an electron microscopic study in dementia of the Alzheimer type. Acta Neuropathol. 1995;90:31–36. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...